Viatris Inc. (NASDAQ:VTRS) Q1 2025 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Viatris Q1 2025 Earnings Call. All participants will be in a listen-only mode.
Viatris Inc (VTRS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Levin Easterly Partners John Murphy | 1,369,559 | $11,928,856 | +81% | 0.99% |
| 2. | Bastion Asset Management Charles Haggar, Mathieu Boisvert, And Michael Gentile | 463,680 | $4,417,340 | -61% | 2.38% |
| 3. | Factorial Partners Mark Kleiman | 292,000 | $2,543,320 | 1.57% | |
| 4. | Neo Ivy Capital Renee Yao | 236,754 | $2,062,127 | 0.66% | |
| 5. | Beddow Capital Management Ed Beddow And William Tichy | 25,120 | $219 | -92% | 0.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.01 | 19 | 94,960 | 2023-10-26 | Filing | ||
| $10.42 | 239 | 94,190 | 2022-03-16 | Filing | ||
| $10.08 | 1,150 | 93,951 | 2022-03-04 | Filing | ||
| $12.84 | 176 | 92,801 | 2021-12-16 | Filing | ||
| $13.81 | 162 | 92,625 | 2021-09-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.88 | 26,925 | 126,901 | 2024-11-11 | Filing | ||
| $11.66 | 139,681 | 505,838 | 2024-09-12 | Filing | ||
| $11.71 | 60,319 | 0 | 2024-09-12 | Filing | ||
| $12.00 | 50,000 | 60,319 | 2024-08-30 | Filing | ||
| $11.90 | 50,000 | 110,319 | 2024-08-28 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 144,627,425 | $1,259,704,872 | 0.02% | |
| 2. | 97,024,557 | $845,083,887 | 0.02% | |
| 3. | 12,148,977 | $105,817,590 | 0.02% | |
| 4. | 11,620,489 | $101,214,459 | 0.57% | |
| 5. | 11,358,101 | $98,929,060 | 0.23% |
News See All
11 Worst Performing Stocks in S&P 500 So Far in 2025
After a two-year surge of 53%, marking the best performance for the broad market index since the 1997-98 rally, stocks have been taken for a wild ride in 2025 due to uncertainties around recent tariffs...
10 Cheap Quarterly Dividend Stocks to Buy Now
In the current market environment, investors are looking to seek stable income as a way to protect themselves against a possible recession.
Billionaire Ken Fisher's 10 Healthcare Stock Picks with Massive Upside Potential
The healthcare industry, an essential component of global well-being and economic resilience, is undergoing significant changes.
10 Best Cheap Stocks to Buy Under $10
On April 21, Tom Lee, Fundstrat CIO, co-founder, and managing partner, joined 'Squawk Box' on CNBC to discuss the latest market trends and stated that the market may be past peak uncertainty despite the...
Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn
Wall Street has come down crashing on President Donald Trump’s sweeping tariffs, raising the risk of a trade war that could push the global economy into recession.
13 High-Dividend Stocks to Invest In Under $10
Investors often favor dividend stocks for their long-term potential, with their appeal stemming from the consistent growth they tend to deliver over time.
10 Oversold Stocks to Buy in 2025 Amid Inflation Fears
The stock market continues to face significant volatility, with major indices continuing their decline from last week.
10 Best Stocks to Buy According to Billionaire David Einhorn
David Einhorn is a highly regarded hedge fund manager, who co-founded Greenlight Capital in 1996.
12 Best Nasdaq Stocks Under $20 to Buy Now
The Nasdaq has had a challenging start to 2025, with the index dropping nearly 12% YTD, as of March 13.
Billionaire Hedge Funds
